Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242216537 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lucile Grzesiak und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institute of Cardiovascular and Metabolic Disease, 31432 Toulouse, France. Hauptthemen laut MEDLINE: Atherosclerosis, Renal Insufficiency, Chronic, Vascular Calcification. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm, Agence Nationale de la Recherche, European Union.
Abstract (Originalsprache)
Atherosclerosis is the primary cause of cardiovascular disease. The development of plaque complications, such as calcification and neo-angiogenesis, strongly impacts plaque stability and is a good predictor of mortality in patients with atherosclerosis. Despite well-known risk factors of plaque complications, such as diabetes mellitus and chronic kidney disease, the mechanisms involved are not fully understood. We and others have identified that the concentration of circulating leucine-rich α-2 glycoprotein 1 (LRG1) was increased in diabetic and chronic kidney disease patients. Using apolipoprotein E knockout mice (ApoE−/−) (fed with Western diet) that developed advanced atherosclerosis and using human carotid endarterectomy, we showed that LRG1 accumulated into an atherosclerotic plaque, preferentially in calcified areas. We then investigated the possible origin of LRG1 and its functions on vascular cells and found that LRG1 expression was specifically enhanced in endothelial cells via inflammatory mediators and not in vascular smooth muscle cells (VSMC). Moreover, we identified that LRG1 was able to induce calcification and SMAD1/5-signaling pathways in VSMC. In conclusion, our results identified for the first time that LRG1 is a direct contributor to vascular calcification and suggest a role of this molecule in the development of plaque complications in patients with atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institute of Cardiovascular and Metabolic Disease, 31432 Toulouse, France.
- Department of Biology, Université Toulouse III Paul-Sabatier, 31062 Toulouse, France.
ORCID-Profile: Lucile Grzesiak, Ana Amaya-Garrido, Marie-Kerguelen Sarthou, Amandine Wahart, Damien Ramel, Julie Klein, Muriel Laffargue
Förderung
- Inserm
- Agence Nationale de la Recherche
- European Union
- FEDER-région Occitanie
- Toulouse University
- Inserm, the European Union ERA CVD JTC2017
- European Union’s Horizon 2020 Research and Innovation programme under the Marie Skłodowska-Curie
- National Research Agency
Zitieren
APA
Grzesiak, L., Amaya-Garrido, A., Feuillet, G., Malet, N., Swiader, A., Sarthou, M. K., Wahart, A., Ramel, D., Gayral, S., Schanstra, J. P., Klein, J., & Laffargue, M. (2023). Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216537
Vancouver
Grzesiak L, Amaya-Garrido A, Feuillet G, Malet N, Swiader A, Sarthou MK, et al. Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216537
BibTeX
@article{Grzesiak2023,
author = {Grzesiak, Lucile and Amaya-Garrido, Ana and Feuillet, Guylène and Malet, Nicole and Swiader, Audrey and Sarthou, Marie-Kerguelen and Wahart, Amandine and Ramel, Damien and Gayral, Stéphanie and Schanstra, Joost Peter and Klein, Julie and Laffargue, Muriel},
title = {Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242216537}
}
EUVIMED